MedPath

Ross Operation Failure Database

Withdrawn
Conditions
Ross Operation
Structural Valve Degeneration
Pulmonary Autograft
Interventions
Procedure: Ross Operation
Registration Number
NCT03027804
Lead Sponsor
Centre Cardiologique du Nord
Brief Summary

A large multicentric registry to obtain data to analyse the pulmonary autograft (PA) failure phenomenon and feed more complex biomechanical models to be integrated with clinical imaging with the final aim to predict Ross operation's outcomes and define strategies to ameliorate its results.

Detailed Description

On the basis of the current knowledge on the outcomes of Ross Operation we aim to create a large multi centric registry in order to obtain data on the preoperative intraoperative management of these patients and on the postoperative long-term results of this procedure.

Patients data will be entered by the investigators in an electronic database Preoperative variables will include age, comorbidities, functional status, indications for surgery, morphology of the aortic valve Additional morphological data and aortic and pulmonary measurements will be taken intraoperatively Postoperative follow-up data including both clinical outcomes (mortality, reoperation for pulmonary autograft failure, major cardiac events, stroke, infection) and morphological measurements by means of CT scan or echocardiography, will be inserted.

Quality of life by means of SF12 and Minnesota living with heart failure questionnaire and EQ-5D score will be collected.

Follow-up endpoints are at discharge, 1 year 5 years 10 years 15 years and 20 years.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients undergone (or undergoing) to Ross Operation
Exclusion Criteria
  • Patients requiring combined cardiac surgical procedure in association to Ross Operation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Ross OperationRoss OperationPatients undergone Ross Operation. Patients requiring reoperation
Primary Outcome Measures
NameTimeMethod
Quality of life-3from inclusion to 20 years follow-up

Quality of life as measured withEQ 5D score

Cardiac Deathfrom inclusion to 20 years follow-up

Mortality due to cardiac cause

Reoperation for Pulmonary Autograft Failurefrom inclusion to 20 years follow-up

Need for reoperation due to failure of pulmonary autograft or valve degeneration

Quality of life-1from inclusion to 20 years follow-up

Quality of life as measured with SF-12

Rehospitalization for heart failurefrom inclusion to 20 years follow-up

Readmission to hospital for heart failure

Survivalfrom inclusion to 20 years follow-up

Death from any cause

Strokefrom inclusion to 20 years follow-up

neurological stroke with impairment

Quality of life-2from inclusion to 20 years follow-up

Quality of life as measured with Minnesota living with heart failure questionnaire

Secondary Outcome Measures
NameTimeMethod
Postoperative complicationspostoperative period (1-30 days)

Combined outcome including bleeding, arrhythmia, respiratory failure, renal failure

Trial Locations

Locations (1)

Centre Cardiologique Du Nord

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath